Nantahala Capital Management’s TELA Bio TELA Stock Holding History

Nantahala Capital Management’s Portfolio TELA Stock Details TELA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$465K	Hold	750,000	–	–	0.02%	147
2025 Q4	$885K	Hold	750,000	–	–	0.03%	140
2025 Q3	$1.12M	Hold	750,000	–	–	0.04%	140
2025 Q2	$1.46M	Hold	750,000	–	–	0.06%	128
2025 Q1	$915K	Hold	750,000	–	–	0.04%	125
2024 Q4	$2.27M	Hold	750,000	–	–	0.1%	106
2024 Q3	$1.9M	Buy	+750,000	New	+$2.67M	0.1%	100

Other funds holding TELA

EWM

Essex Woodlands Management The Woodlands, Texas $254M AUM 4.59% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

SCM

Silverarc Capital Management Boston, Massachusetts $980M AUM 470.8% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

DCM

DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return

PCM

Perkins Capital Management Wayzata, Minnesota $133M AUM 127.86% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

SCM

Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Nantahala Capital Management's TELA Position: Q1 2026 in Review

Nantahala Capital Management increased its TELA Bio (TELA) stake by 0.64% in Q1 2026, buying an estimated $28.2K and bringing the position to 5,144,114 shares worth $3.19M. The position accounts for 0.12% of the portfolio, ranked #117.

Nantahala Capital Management first reported a position in TELA in Q3 2022 and has held it in 15 quarters since. The position peaked at $11.5M in Q2 2024. 36 funds tracked by Wall St. Rank hold TELA as of Q1 2026.

Nantahala Capital Management held 5,144,114 shares of TELA Bio worth $3.19M as of Q1 2026.
Nantahala Capital Management bought 32,526 TELA Bio shares in Q1 2026, an estimated $28.2K.
TELA Bio made up 0.12% of Nantahala Capital Management's portfolio in Q1 2026, its #117 holding.
Nantahala Capital Management first reported a position in TELA Bio in Q3 2022 and has held it in 15 quarters since.
Nantahala Capital Management's TELA Bio position peaked at $11.5M in Q2 2024.
36 funds tracked by Wall St. Rank held TELA Bio as of Q1 2026.

Based on Nantahala Capital Management's 13F filing for Q1 2026, filed 15 May 2026.